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Abstract
We previously demonstrated that skeletal structure and strength phenotypes vary considerably in 
heterogeneous stock (HS) rats. These phenotypes were found to be strongly heritable, suggesting 
that the HS rat model represents a unique genetic resource for dissecting the complex genetic 
etiology underlying bone fragility. The purpose of this study was to identify and localize genes 
associated with bone structure and strength phenotypes using 1524 adult male and female HS rats 
between 17 to 20 weeks of age. Structure measures included femur length, neck width, head 
width; femur and lumbar spine (L3-5) areas obtained by DXA; and cross-sectional areas (CSA) at 
the midshaft, distal femur and femoral neck, and the 5th lumbar vertebra measured by CT. In 
addition, measures of strength of the whole femur and femoral neck were obtained. Approximately 
70,000 polymorphic SNPs distributed throughout the rat genome were selected for genotyping, 
with a mean linkage disequilibrium coefficient between neighboring SNPs of 0.95. Haplotypes 
were estimated across the entire genome for each rat using a multipoint haplotype reconstruction 
method, which calculates the probability of descent at each locus from each of the 8 HS founder 
*Corresponding author: Imranul Alam, PhD, Division of Endocrinology, Indiana University School of Medicine, 1120 W. Michigan 
St, CL459, Indianapolis, IN 46202, Phone (317) 274-0744, Fax (317) 278-0658, ialam@iu.edu. 
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our 
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of 
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Conflict of Interest: All authors have no conflicts of interest.
Authors’ roles
Study design: IA, DLK, MJE, and TF. Study conduct: IA, DLK, TC, GB, CM, RL, EM, SD, AT, AF, PS, MD, TO, MJ, and AB. Data 
analysis: IA, DLK, AB, and TF. Data interpretation: IA, DLK, MJE and TF. Drafting manuscript: IA and DLK. Revising manuscript 
content: IA, DLK, AF, MJE, and TF. Approval of final version of manuscript: IA, DLK, TC, GB, CM, RL, EM, SD, AT, AF, PS, 
MD, TO, MJ, AB, MJE and TF.
HHS Public Access
Author manuscript
Bone. Author manuscript; available in PMC 2016 December 01.
Published in final edited form as:
Bone. 2015 December ; 81: 417–426. doi:10.1016/j.bone.2015.08.013.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
strains. The haplotypes were then tested for association with each structure and strength phenotype 
via a mixed model with covariate adjustment. We identified quantitative trait loci (QTLs) for 
structure phenotypes on chromosomes 3, 8, 10, 12, 17 and 20, and QTLs for strength phenotypes 
on chromosomes 5, 10 and 11 that met a conservative genome-wide empiric significance threshold 
(FDR=5%; P<3 × 10−6). Importantly, most QTLs were localized to very narrow genomic regions 
(as small as 0.3Mb and up to 3 Mb), each harboring a small set of candidate genes, both novel and 
previously shown to have roles in skeletal development and homeostasis.
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Introduction
Osteoporosis is a common, genetically complex disorder characterized by reduced bone 
mineral density (BMD), abnormal bone microarchitecture and compromised bone strength 
leading to increased susceptibility to fracture risk [1]. Bone mineral density (BMD), 
structure and strength are the major determinants of skeletal fracture [2-4]. As much as 80% 
of the variability of BMD and about one-third of the variance in the risk of fracture is due to 
heritable factors [5-8]. Although BMD by DXA is most often used for predicting fracture 
risk in humans, it is not an adequate measure to capture several important aspects of bone 
strength. The genetic basis of fracture susceptibility depends on coordination of bone 
density, morphology, structure and tissue-quality, all of which contribute to bone strength. 
Identification and characterization of genes underlying bone structure and strength, 
particularly at the most common sites of fracture, will ultimately lead to better diagnosis, 
prevention and treatment of osteoporosis and other high bone-fragility conditions.
Previously, we identified several quantitative trait loci (QTLs) linked to bone structure and 
strength phenotypes in inbred F344, LEW, COP and DA rats [9-12]. However, most of these 
QTLs are large (20-30 cM) and harbor hundreds of potential candidate genes. It is a 
formidable challenge to narrow these critical QTL regions to a small chromosomal segment 
containing a few genes. To address this issue, in this study we exploited a unique rat model, 
the heterogeneous stock (HS) rat, developed by the National Institutes of Health (NIH) in 
1984 [13]. These rats were derived from eight inbred founder strains: Agouti (ACI/N), 
Brown Norway (BN/SsN), Buffalo (BUF/N), Fischer 344 (F344/N), M520/N, Maudsley 
Reactive (MR/N), Wistar-Kyoto (WKY/N) and Wistar-Nettleship (WN/N) [13-14]. 
Importantly, the descendants of these rats represent a unique, genetically random mosaic of 
the founding animals’ chromosomes due to recombination that has accumulated over 50 
generations, enabling the fine mapping of QTLs to very small genomic regions. Recently, 
these rats have been successfully used for high-resolution mapping for diabetes and fear-
related behavior phenotypes [15-16].
In a previous study, we demonstrated that bone structure and strength phenotypes vary 
considerably among the HS founder strains [17]. Recently, using the sequence data from 
these strains and genotypes for a dense SNP marker map in the HS offspring population, we 
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identified several QTLs and underlying genetic variants for multiple bone phenotypes [18]; 
however, no single genetic variants explaining associations with bone phenotypes were 
detected, consistent with the complex genetic architecture of skeletal phenotypes observed 
previously both in humans and animal models [18-19]. The purpose of this study is to 
identify and localize QTLs for bone structure and strength phenotypes using high-resolution 
mapping in the HS rat offspring at the most common skeletal fracture sites. We anticipate 
that using this approach the bone structure and strength QTLs will be localized to much 
smaller genomic regions than QTLs detected using inbred rat crosses. Ultimately, this will 
allow us to identify a smaller set of potential candidate genes underlying these QTLs, and 
contribute to a better understanding of the complex genetic architecture of the fracture risk 
phenotypes in the rat model and in human.
Materials and Methods
Animals
We used 1524 HS rats (male n=728; female n=796) in this study. The HS rats were bred and 
grown at the Autonomous University of Barcelona. The rats were housed in cages in pairs 
(males) and trios (females) and maintained with food and water available ad libitum. The HS 
rats were raised over 2.5 years in batches of approximately 250 animals in accordance with 
the Spanish legislation on “Protection of Animals used for Experimental and Other 
Scientific Purposes” and the European Communities Council Directive (86/609/EEC).
Euthanasia and specimen collection
HS rats were euthanized between 17 and 20 weeks of age by ether inhalation. The lower 
limbs and lumbar vertebrae (L3-5) were dissected from these animals. The lower limbs on 
the right side were immediately frozen after harvest wrapped in saline soaked gauge in 
plastic Ziplock bags at −20°C for subsequent biomechanical testing. To prevent dehydration 
and any adverse effect on the mechanical properties, we kept the muscle attached to the 
limbs during the storage period until testing. The lower limbs on the left side and lumbar 
vertebrae (L3-5) were stripped of muscle, transferred to 70% ethyl alcohol and stored at 4°C 
for bone structure analyses.
Dual energy X-ray absorptiometry (DXA)
The left femur and lumbar vertebrae 3-5 (L3-5) of the HS rats were scanned using DXA 
(PIXImus II mouse densitometer; Lunar Corp., Madison, WI, USA) with ultra-high 
resolution (0.18 × 0.18 mm/pixel). The machine was calibrated prior to each DXA scanning 
session using a phantom supplied by the manufacturer. During scanning dissected femurs 
were positioned with anterior surface facing up and the distal end on left side whereas L3-5 
were oriented anterior surface facing up on a standardized platform in air. After completion 
of the scan of each bone, mutually exclusive region of interest (ROI) boxes were drawn 
manually around the bones from which femur area (mm2) and lumbar area (mm2) 
measurements were obtained. The intra-specimen % coefficient variation for area was less 
than 1%.
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Femur length, femoral head and neck width measurements
The femur size parameters were measured using digital calipers accurate to 0.01 mm, with a 
precision of ± 0.005 mm (Mitutoyo, Aurora, IL). The femur length (mm) was measured 
from the end of the medial condyle to the end of the greater trochanter. The maximum 
transverse diameter (mm) of the femoral head and the shortest transverse distance (mm) of 
the femoral neck were considered as the width of the femoral head and neck, respectively.
Peripheral quantitative computed tomography (pQCT)
The left femurs were placed in plastic tubes filled with 70% ethyl alcohol and centered in 
the gantry of a Norland Stratec XCT Research SA+pQCT (Stratec Electronics, Pforzheim, 
Germany) machine. Single slice measurements of 0.26 mm thickness and a voxel size of 
0.07 mm were taken for the femur: one slice through femoral midshaft and one slice 
approximately 1 mm below the growth plate of distal femur. L5 vertebrae were scanned in 
cross-section at the caudo-cranial center of the vertebral body. For femoral neck, five 
consecutive scans perpendicular to the neck axis were obtained 0.25 mm apart from each 
other starting at the base of the femoral head and ending at the greater trochanter. For each 
slice, the X-ray source was rotated through 180° of projection. Total (trabecular and cortical) 
cross-sectional area (CSA; mm2) from each slice for femur and L5 spine were measured 
using the thresholds of 500 and 900 mg/cm3. For femoral neck, CSA were measured from 
the average values of all five slices.
Biomechanical testing
The frozen right femurs were brought to room temperature slowly in a saline bath. The 
femurs were tested in three-point bending by positioning them with anterior surface facing 
up and the distal end as close to the left supporting point as possible on the lower supports 
(15 mm span for female and 20 mm span for male) of a three-point bending fixture and 
applying load at the midpoint using a material testing machine (Alliance RT/5, MTS 
Systems Corp., Eden Prairie, USA). For femoral neck, the proximal end of the femurs was 
mounted vertically in a special chuck that clamped the femoral shaft to the lower platen of 
the same material testing machine. The bones were held in place by a small (1N) preload, 
and then load was applied directly downward at a crosshead speed of 20 mm/min onto the 
mid-femur and femoral head at room temperature in monotonic axial compression until 
fracture. Force and displacement measurements were collected every 0.05 second. From the 
force vs. displacement curves, we measured the phenotypes that are critical for different 
aspects of bone fragility - ultimate force (Fu; N), stiffness (S; N/mm), work to failure (W; 
mJ) and ultimate displacement or elongation (E; mm) in TestWorks software, version 4.06. 
Fu reflects the strength of the bone or maximum load that the bone can support before 
failing; S is the slope of the curve represents the bone brittleness; W reflects the amount of 
energy the specimen can absorb prior to fracture and E is the reciprocal of brittleness. The 
phenotypes, together, best reflect the clinical aspect of skeletal fragility.
Genotyping
DNA was extracted from liver tissues from 8 original founders and 1524 HS rats using 
standard protocols. To reconstruct the genome of each HS rat, genotypes for over 900,000 
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SNPs for each rat were selected from an Affymetrix rat custom SNP array 
(www.affymetrix.com) as described previously [19]. We used only high quality informative 
(SNP call rate more than 0.99, polymorphic SNPs and no missing genotyping) markers. The 
average spacing between adjacent SNPs is 12.5 kb, with a maximum gap size of 1 Mb. The 
maximum density is 15 SNPs in a 10kb window. In addition, there are 19 larger gaps (1-3.8 
Mb) on the autosomes (chromosome 1 to chromosome 20) and 12 larger gaps on 
chromosome X, with a maximum gap of 4.8 Mb. The set of SNPs were pruned to 
approximately 70,000 high quality SNPs which covered the HS rat genome with a mean 
linkage disequilibrium coefficient between neighboring SNPs of 0.95.
Measurements of intra- and inter-observer errors
The structure and strength phenotypes were measured in batches consisting approximately 
250 samples involving multiple individuals, therefore, we analyzed the intra- (measurement 
of a phenotype across multiple samples by an individual) and inter-observer (measurement 
of a phenotype across multiple samples by different individuals) variations for these 
measurements. We found that the intra-observer % of coefficient of variations (CV) for 
femur length (<4%), neck width (<13%), head width (<9%), lumbar area (<18%), femur 
work to failure (<34%), femur elongation (<32%) and femur neck ultimate force (<23%) 
were comparable to inter-observer variations of these measurements (<6%, <12%, 7%, 
<16%, <39%, <25% and <20%, respectively), suggesting that the quality of these 
phenotypic measurements was consistent across all samples in this study.
Statistical genetic analysis
Haplotypes were constructed for each rat across the genome using the multipoint haplotype 
reconstruction method HAPPY (http://www.well.ox.ac.uk/happy) [20] as described 
previously [19]. A mixed model approach was employed to test for association between 
each haplotype and the bone phenotype of interest. Variance components to correct for 
pedigree relationships were estimated using the EMMA package for the R statistical 
software [21]. The test for association was conducted for each phenotype via a mixed model, 
adjusting for age, sex, body weight and batch as described previously [19]. An overall 
significance threshold of P<3 × 10−6 (−log10P=5.5) was used, corresponding to the most 
stringent of the 5% FDR levels established by permutation for each of the bone structure and 
strength phenotypes, and applying a Bonferonni correction for the number of traits 
considered. All models were fitted using the statistical language R (R-Development-Core-
Team 2004) [22]. For each QTL meeting the significance threshold, the resampling-based 
model inclusion probability (RMIP) was obtained as a measure of robustness; QTLs with 
RMIP values above 0.3 were further explored for candidates of interest. A 95% confidence 
interval for the position of each QTL detected was obtained as described previously [9,23].
Results
QTL mapping results were obtained throughout the genome for the structural measurements 
of femur length, neck width, head width and lumbar area (Figure 1A-1D). Results for femur 
work to failure, elongation and femur neck ultimate force are shown in Figure 1E-1G. 
Several QTLs reaching the genome-wide FDR and RMIP significance thresholds were 
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observed in the HS rat sample, and are included in Table 1. Candidate genes within the 95% 
confidence intervals (CI) for these QTLs are listed in Table 2.
Genome-wide significant association results of femur and femoral neck structure
On chromosome 20 at position 34 Mb, significant linkage was detected for femur length 
with a –logP value of 6.72 (p=1.9 × 10−7; Figure 2A and Table 1). The CI for this QTL 
spanned 2.8 megabase (Mb). On chromosome 8, a QTL was identified which was linked to 
femur head width with a –logP value of 6.56 (p=2.7 × 10−7; Figure 2B) spanning less than 
one megabase. On chromosome 3, a QTL was identified which was linked to femur neck 
width with a –logP value of 9.75 (p=1.7 × 10−10; Figure 2C) spanning 2.8 megabase. In 
addition, a QTL encompassing 0.8 Mb for femur neck width with a –logP value of 8.55 
(p=2.7 × 10−9; Figure 2D) was detected on chromosome 17.
Genome-wide significant association results of lumbar spine structure
The only significant QTL for lumbar area was detected on chromosome 12 at position 22 
Mb, with a –logP value of 16.39 (p=4.0 × 10−17; Figure 3A and 4B) spanning 0.5 Mb 
chromosomal region.
Genome-wide significant association results of femur and femoral neck strength
We observed two genome-wide significant QTLs for femur strength phenotypes, one each 
for femur work to failure (Figure 3B and 4A) and femur elongation (Figure 3C) on 
chromosomes 5 and 11, respectively. The CI for the QTL region on chromosome 5 spans 
approximately 2.5 Mb whereas the QTL region on chromosome 11 spans 2.9 Mb. In 
addition, a QTL was identified for femoral neck ultimate force between 46-47 Mb position 
on chromosome 10 (Figure 3D) spanning 0.3 Mb region. In the same region on chromosome 
10, a QTL for femur length was also observed with a significant –logP value of 6.46 (p=3.8 
× 10−7).
Discussion
In this study, we detected and localized QTLs for several key bone structure and strength 
phenotypes in HS rats at most common skeletal fracture sites. Importantly, most of these 
loci were localized to very small genomic regions, as small as 0.5 Mb up to 3 Mb, compared 
to the F2 design used previously for QTL mapping. This approach also allowed us to 
identify a narrowed list of positional candidate genes underlying each QTL, which can then 
be analyzed in future functional studies. Such a direct translation from gene identification to 
functional work is not possible in the traditional F2 design which typically identifies a QTL 
region harboring hundreds of potential candidate genes.
A critical factor for identification of genes underlying any complex trait such as skeletal 
fragility is replication of QTLs across studies. If chromosomal regions truly harbor gene/s 
for a trait, independent studies involving sufficiently large samples will most likely detect 
the same QTL for that particular trait. Importantly, the genomic resolution of replicated 
QTLs could be enhanced, thereby narrowing the number of positional candidate genes, by 
employing a genetically random mosaic model of the founder animals rather than using 
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traditional two-strain parental crosses. Indeed, several chromosomal regions previously 
identified in our inbred F2 studies were replicated in HS rats. For example, we detected 
association with femur work to failure in the HS rats on chromosome 5 (LOD 6.54) (Figure 
3B and 4A), which overlapped with multiple QTLs in our F344 X LEW and COP X DA F2 
crosses for femur structure and strength phenotypes [10,12]. This QTL in HS rat is syntenic 
to human chromosome 1p32.2-p33 and close to the location of the tissue-nonspecific ALP 
gene, which is important for skeletal mineralization. In addition, lumbar area QTL identified 
in HS rats on chromosome 12 (LOD 16.39) (Figure 3A and 4B) overlapped the QTLs in 
COP X DA F2 cross for spinal BMD and trabecular area [9,10,58]. This QTL in HS rats is 
homologous to human chromosome 7q11 (Figure 3A), which was linked to hip and spine 
BMD and femoral neck geometry [55-57]. Importantly, using HS rats, we were able to fine-
map these regions to 1-3 Mb resolution, enabling us to identify a much smaller number of 
potential candidate genes on these overlapped chromosomes (Table 2). Notably, 2 genes 
(Hip1 and Por) underlying the QTL on chromosome 12 have been previously reported to 
have important roles in skeletal development and homeostasis. Hip1, a member of 
Huntingtin interactin protein, plays an important role in the clathrin trafficking network. 
Hip1 deficient mice have developmental abnormalities and growth defects including severe 
spinal abnormalities and dwarfism [40,41]. Por is the primary electron donor for 
cytochromes P450. Mutations in Por in humans lead to severe malformations including 
defects in craniofacial and long bones development [42]. In addition, deletion of Por 
recapitulates the human skeletal defects in mouse model, indicating this gene is important 
for proper bone development [43].
The genes underlying QTLs identified in this study might act alone or in combination to 
influence bone structure and strength phenotypes in different manner. For example, a single 
gene might affect multiple bone phenotypes or a cluster of genes may act together to modify 
a single bone phenotype. Also, the pleiotropic gene/s may contribute not only to different 
bone phenotypes but also influence phenotypes at different skeletal sites even within a given 
bone. Indeed, we detected several QTLs in HS rats that overlapped the QTLs in F344 X 
LEW and COP X DA F2 crosses for different bone phenotypes. The head width QTL in HS 
rats on chromosome 8 (LOD 6.56) (Figure 2B) overlapped with femur BMD and femoral 
neck strength QTLs in COP X DA cross [9,10]. The femur length and femur neck ultimate 
force QTLs identified in HS rats on chromosome 10 (LOD 6.41) (Figure 3D) overlapped the 
QTLs for spine BMD in both F344 X LEW and COP X DA F2 crosses [9,44]. This region 
was also coincided with the position of the femur BMC QTL that we reported previously in 
HS rat [19]. Similarly, the femur length QTL identified in HS rats on chromosome 20 (LOD 
6.72) (Figure 2A) overlapped the QTL for femur BMD in COP X DA F2 cross [9]. The QTL 
region for femoral head width on chromosome 8 in HS rat is syntenic to human chromosome 
6q13-14 (Figure 2B). This region was previously linked to osteoarthritis QTL and hand-foot 
malformation [49,52]. A locus for otosclerosis, a common form of hearing impairment 
caused by abnormal bone homeostasis of the otic capsule, was mapped to the 6q13-16 
region [59]. In addition, 6q14.2-14.3 region harbors gene for cleft lip and palate, a defect of 
craniofacial development in human [60]. The distal peaks of QTLs for ALP and OC in 
baboon were mapped close to human orthologous 6q13 region [61]. The femur length QTL 
on chromosome 10 in HS rat is homologous to the human chromosomes 1q42-44 and 
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17p11.2 which were linked to rheumatoid arthritis QTL and hip BMD, respectively (Figure 
3D) [45,46]. The susceptibility loci for split-hand/foot malformation with long-bone 
deficiency, a rare severe limb deformity condition were detected at 1q42.2-q43 and 6q14.1 
[62]. Furthermore, a locus for Kenny-Caffey syndrome, an osteosclerotic bone dysplasia 
was identified at 1q42-q43 [63]. Amplification and overexpression of genes in 17p11.2-p12 
leads to osteosarcoma [64]. QTLs for developmental components of the craniofacial 
complex were mapped to baboon ortholog of human chromosome 17p12 [65]. The neck 
width QTL on chromosome 17 in HS rat is homologous to the human chromosomes 
10p12.1-p13, where Paget's disease locus was mapped [66-68]. The QTL for the femur 
length on chromosome 20 in HS rats is syntenic to 6q21-22 where spine and heel BMD 
QTLs were detected (Figure 2A) [47,48]. In addition, this human region was linked to 
osteoarthritis and rheumatoid arthritis QTLs [45,49]. Mutation in a locus of 6q21 harboring 
OSTM1 gene was found to be linked to human malignant infantile osteopetrosis and 
craniometaphyseal dysplasia with severe craniofacial involvement shows hmozygosity at 
6q21-q22.1 locus in human [69,70]. Among all the genes detected underlying QTL on 
chromosome 10, several genes have previously shown to play important functions in bone 
growth and remodeling (Table 2). Cops3 is an oncogene residing in the human chromosomal 
region 17p11.2-p12 - the copy number and expression level of Cops3 was significantly 
associated with the development of osteosarcoma, the most common primary malignancy of 
bone [29,30]. Drg2, a GTP binding protein, overexpression of which in transgenic mice 
leads to increased number and activity of osteoclasts and bone loss [31]. Map2k3 is 
increased by RANKL, which in turn aids in osteoclastogenesis from bone marrow precursor 
cells [39]. Nlrp3, a member of the NLR family of cytosolic receptors, mediates bone loss at 
sites of infection by apoptotic cell death of osteoblasts [36]. Mutations in Nlrp3 are 
responsible for neonatal-onset multisystem inflammatory disease, exhibiting growth 
retardation, osteopenia and increased osteoclastogenesis [37], suggesting that this gene is 
important for postnatal skeletal growth and bone remodeling. Rai1 encodes a nuclear protein 
containing a zinc finger homeodomain and regulates cell growth, cell cycle regulation, lipid 
metabolism, neurological development and behavioral functions [32-33]. Mutation of Rai 
leads to craniofacial and skeletal anomalies (short extremities) in Smith-Magenis syndrome 
[32]. Both the copy number and expression level of Rasd1 were significantly associated with 
the development of osteosarcoma [29]. In addition, using an integrative genetics approach, 
Rasd1 was identified as a strong candidate gene for a BMD QTL in mice [34]. Srebf1 
activates genes that regulate lipid biosynthesis, and polymorphism in this gene was found to 
be associated with a higher risk of osteonecrosis of the femoral head in the Korean 
population [35]. Shmt1 and Top3a are oncogenes and contribute to the development of 
osteosarcoma [29,38].
Two novel chromosomal regions linked to bone structure and strength phenotypes were 
identified in HS rats (Table 1) not found in our F2 studies. On chromosome 3, a QTL was 
identified for neck width (Figure 2C) and on chromosome 11 we detected a QTL for femur 
strength (Figure 3C). The QTL region for femoral neck width on chromosome 3 in HS rat is 
syntenic to human 9q33-34 (Figure 2C), where linkage to neck BMD and osteoarthritis and 
rheumatoid arthritis QTLs were detected previously [45,50,51]. KBG syndrome, a postnatal 
short stature, macrodontia, facial and hand anomalies and delayed bone age was associated 
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with 9q31.2-q33.1 [71]. The femur elongation QTL on chromosome 11 in HS rats is 
syntenic to human chromosome 3q11-13 and 3q12-26 (Figure 3C), where femur and hip 
structural QTLs and QTL for rheumatoid arthritis were observed [45,53,54]. QTLs for 
developmental components of the craniofacial complex were mapped to baboon ortholog of 
human chromosome 3q11-13 [65]. Three genes (Gsn, Hspa5 and Lmx1b) underlying the 
QTL on chromosome 3 play important roles in bone and teeth development (Table 2). A 
haplotype in Gsn (gelsolin) was associated with the hip bone phenotypes, and mRNA and 
protein expressions of Gsn in peripheral blood monocytes were lower in female Caucasians 
with low hip BMD [28]. Hspa5 (heat shock 70kDa protein 5) or GRP-78, an endoplasmic 
reticulum chaperone protein localized on the plasma membrane in preosteoblasts, is 
responsible for cellular uptake of Dmp1 for its internalization to the nucleus during bone and 
tooth development [27]. Lmx1b is required for patterning and morphogenesis of the mouse 
calvaria and is necessary for dorsal-ventral patterning during limb development in mice 
[24-26].
Several novel genes underlying QTLs discovered in this study were not previously directly 
linked to any bone phenotype but they code for proteins for various cellular structures and 
trafficking pathways – such as membrane proteins (Impg1, Senp6, Lrrc48, Dcbld2, Jmjd4 
and Gabrr3), membrane trafficking (Gapvd1, Llgl1 and Tom1l2), cytoskeletal proteins 
(Stom, Mprip and Tom1l2) and cell junction proteins (Myo6, Myo15a and Dcbld2) that 
might be important for overall bone homeostasis (Table 2). Also, genes that act as 
transcription factors or cofactors (Rhbdd2, Zbtb34/43 and Msl3l2), G-protein coupled 
receptors (Gpr15, Mprip, Myo6 and Myo15a), small GTPase (Arl6 and Arl5b) and calcium 
binding proteins (Flii and Fkbp6) were identified (Table 2). These genes might play role in 
connection between skeletal metabolism and other systems functions.
There are some limitations in this study. Although, rat skeleton is very similar to human 
bone with peak bone mass gain or bone loss due to aging, and rat models have served as a 
highly predictive model for fracture risk in humans, a potential drawback is rat skeleton 
lacks the Haversian remodeling system found in human. Also, we could not identify any 
specific sequence variants in the HS founder strains that fully accounted for structure and 
strength QTLs identified in this study. In the future, full sequence information of HS 
offspring will shed light on the complex genetic interactions among the different haplotype 
variants underlying these phenotypes in these animals. Furthermore, while QTLs for bone 
structure and strength phenotypes in the HS rat were localized to very small genomic 
regions, further functional studies are necessary to identify the causative genes from these 
narrowed lists of candidate genes.
In this study, we demonstrated that HS rats are a powerful resource for fine mapping of 
QTLs for bone structure and strength phenotypes. These phenotypes, along with BMD, are 
complex in nature in the rat, just as they are in humans and are likely due to multiple 
variants inherited from different founders as well as interactions among these variants. The 
number of founder rat lines used in the generation of the HS population and the number of 
recombination events accumulated over many generations, allowed us to more accurately 
detect the correct QTL position. Most importantly, this approach allows us to delineate a 
much smaller chromosomal QTL interval and thus generate a narrower list of potential 
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candidate genes than the traditional F2 approach – which is a cross of only two founder rat 
lines. In the future, sequencing studies in the HS offspring in these narrowed regions, along 
with analysis of the founder strain sequence data, will enable us to dissect the complex 
genetic architecture underlying the structure and strength phenotypes in the HS rats.
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Highlights
• We detected QTLs for bone structure and strength phenotypes in HS rats at the 
most common skeletal fracture sites
• Several chromosomal regions previously identified in our inbred F2 cross were 
replicated in HS rats
• Most QTLs in HS rats were localized to very narrow genomic regions
• HS rat model allowed us to identify a narrower list of potential candidate genes 
than the traditional F2 approach
• We demonstrated that HS rats are a powerful resource for fine mapping of QTLs 
for bone structure and strength phenotypes
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Fig. 1. 
Genome-wide plots for femur length (A), femur neck width (B), femur head width (C), 
lumbar area (D), femur work to failure (E), femur elongation (F), and femur neck ultimate 
force (G). The –log10P values plotted on the Y-axis versus chromosome position on the X-
axis. For comparability with other mapping studies, QTL results are shown at each position 
regardless of the conservative RMIP threshold (0.3) employed to select the most robust 
QTLs for our report. The dashed horizontal lines indicate the threshold value for genome-
wide significance corresponding to FDR=5% (p<3 × 10−6).
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Fig. 2. 
Association results for femur length on chromosome 20 (A), femur head width on 
chromosome 8 (B), femoral neck width on chromosome 3 (C) and femoral neck width on 
chromosome 17 (D). The –logP values are plotted on the Y-axis vs. the chromosomal 
position (MB) on the X-axis. The dashed horizontal lines indicate the threshold value for 
genome-wide significance corresponding to FDR=5% (p<3 × 10−6). Corresponding human 
syntenic regions and associated QTLs for bone phenotypes are indicated.
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Fig. 3. 
Association results for lumbar area on chromosome 12 (A), femur work to failure on 
chromosome 5 (B), femur elongation on chromosome 11 (C), and femoral neck ultimate 
force, femur length and midshaft area on chromosome 10 (D). The –logP values are plotted 
on the Y-axis vs. the chromosomal position (MB) on the X-axis. The dashed horizontal lines 
indicate the threshold value for genome-wide significance corresponding to FDR=5% (p<3 
× 10−6). Corresponding human syntenic regions and associated QTLs for bone phenotypes 
are indicated.
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Fig. 4. 
Mapping results on chromosome 5 (A) for femur work to failure and on chromosome 12 (B) 
for lumbar area, indicating evidence for QTLs from the HS analysis (solid line) and an F2 
intercross (F344 X LEW or COP X DA) reported previously (dotted line). Black triangles 
along the x-axis correspond to the positions of microsatellite markers typed on each 
chromosome for the particular F2 intercross.
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